Shingo Kyotani
About
In The Last Decade
Shingo Kyotani
60 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Pulmonary and Respiratory Medicine 3.6k
- Cardiology and Cardiovascular Medicine 2.9k
- Genetics 637
- Surgery 546
- Epidemiology 537
Countries citing papers authored by Shingo Kyotani
This map shows the geographic impact of Shingo Kyotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Kyotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Kyotani more than expected).
Fields of papers citing papers by Shingo Kyotani
This network shows the impact of papers produced by Shingo Kyotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Kyotani. The network helps show where Shingo Kyotani may publish in the future.
Co-authorship network of co-authors of Shingo Kyotani
This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Kyotani. A scholar is included among the top collaborators of Shingo Kyotani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Kyotani. Shingo Kyotani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Abstract 19627: Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension | 1 |
| 2 | 31 | |
| 3 | 13 | |
| 4 | 51 | |
| 5 | 1 Management of Continuous Intravenous Prostacyclin therapy for Pulmonary arterial Hypertension(Which drug is useful for the treatment of pulmonary hypertension?,Topic 4 (TP4) (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) | 1 |
| 6 | 70 | |
| 7 | 40 | |
| 8 | 16 | |
| 9 | 143 | |
| 10 | 33 | |
| 11 | 67 | |
| 12 | 74 | |
| 13 | 152 | |
| 14 | 52 | |
| 15 | Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension: Comparison with Cardiopulmonary Exercise Testing breakdown → | 857 |
| 16 | 211 | |
| 17 | 156 | |
| 18 | 26 | |
| 19 | 70 | |
| 20 | 60 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.